Did you know that today, you likely interacted with someone with a rare disease? One in 20 people are living with a rare disease, which equates to roughly 350 million people worldwide. Currently, there are 7,000 known rare diseases, of which only 5% have treatment options.* At Shire, we are passionate about closing this gap and creating therapies for these underserved populations.
Come join us and learn about the importance of “rare” and how common “rare” really is. We will be sharing insights about the unique people we serve across our core therapeutic areas while serving food and beverages to help raise awareness of the opportunity to champion these patients and their families.
Cost: Free . RSVP at bit.ly/2oZrbwH
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class medicines, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine, Hereditary Angioedema and Oncology. We look forward to meeting you soon.